The multidisciplinary management of rectal cancer
- PMID: 32203400
- DOI: 10.1038/s41575-020-0275-y
The multidisciplinary management of rectal cancer
Abstract
Rectal cancer treatment has evolved during the past 40 years with the use of a standardized surgical technique for tumour resection: total mesorectal excision. A dramatic reduction in local recurrence rates and improved survival outcomes have been achieved as consequences of a better understanding of the surgical oncology of rectal cancer, and the advent of adjuvant and neoadjuvant treatments to compliment surgery have paved the way for a multidisciplinary approach to disease management. Further improvements in imaging techniques and the ability to identify prognostic factors such as tumour regression, extramural venous invasion and threatened margins have introduced the concept of decision-making based on preoperative staging information. Modern treatment strategies are underpinned by accurate high-resolution imaging guiding both neoadjuvant therapy and precision surgery, followed by meticulous pathological scrutiny identifying the important prognostic factors for adjuvant chemotherapy. Included in these strategies are organ-sparing approaches and watch-and-wait strategies in selected patients. These pathways rely on the close working of interlinked disciplines within a multidisciplinary team. Such multidisciplinary forums are becoming standard in the treatment of rectal cancer across the UK, Europe and, more recently, the USA. This Review examines the essential components of modern-day management of rectal cancer through a multidisciplinary team approach, providing information that is essential for any practising colorectal surgeon to guide the best patient care.
Similar articles
-
Neoadjuvant radiotherapy for rectal cancer management.World J Gastroenterol. 2019 Sep 7;25(33):4850-4869. doi: 10.3748/wjg.v25.i33.4850. World J Gastroenterol. 2019. PMID: 31543678 Free PMC article. Review.
-
Biology-and Location-Oriented Precision Treatment of Rectal Cancer: Present and Future.Visc Med. 2020 Oct;36(5):381-387. doi: 10.1159/000510488. Epub 2020 Sep 16. Visc Med. 2020. PMID: 33178735 Free PMC article. Review.
-
"Watch and Wait" for complete clinical response after neoadjuvant chemoradiotherapy for rectal cancer.Minerva Chir. 2019 Dec;74(6):481-495. doi: 10.23736/S0026-4733.19.08184-7. Epub 2019 Sep 30. Minerva Chir. 2019. PMID: 31580047
-
Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.Dis Colon Rectum. 2020 Apr;63(4):427-440. doi: 10.1097/DCR.0000000000001558. Dis Colon Rectum. 2020. PMID: 31996583
-
Preoperative tumour staging with multidisciplinary team assessment improves the outcome in locally advanced primary rectal cancer.Colorectal Dis. 2011 Dec;13(12):1361-9. doi: 10.1111/j.1463-1318.2010.02460.x. Colorectal Dis. 2011. PMID: 20958913
Cited by
-
Predictive value of indirect bilirubin before neoadjuvant chemoradiotherapy in evaluating prognosis of local advanced rectal cancer patients.World J Gastrointest Oncol. 2022 Nov 15;14(11):2224-2237. doi: 10.4251/wjgo.v14.i11.2224. World J Gastrointest Oncol. 2022. PMID: 36438711 Free PMC article.
-
Outcomes of Watch-and-Wait Versus Abdominoperineal Resection in Lower Rectal Adenocarcinoma Post Neoadjuvant Therapy: An Iraqi Cohort Study.Cureus. 2024 Aug 27;16(8):e67955. doi: 10.7759/cureus.67955. eCollection 2024 Aug. Cureus. 2024. PMID: 39328707 Free PMC article.
-
Current Surgical Methods in Local Rectal Excision.Gastrointest Tumors. 2024 Apr 17;10(1):44-56. doi: 10.1159/000538958. eCollection 2023 Jan-Dec. Gastrointest Tumors. 2024. PMID: 39015761 Free PMC article. Review.
-
Risk factors for severe low anterior resection syndrome in patients with rectal cancer undergoing sphincter‑preserving resection: A systematic review and meta‑analysis.Oncol Lett. 2023 Nov 22;27(1):30. doi: 10.3892/ol.2023.14163. eCollection 2024 Jan. Oncol Lett. 2023. PMID: 38108080 Free PMC article.
-
An IT Platform Supporting Rectal Cancer Tumor Board Activities: Implementation Process and Impact Analysis.Int J Environ Res Public Health. 2022 Nov 28;19(23):15808. doi: 10.3390/ijerph192315808. Int J Environ Res Public Health. 2022. PMID: 36497903 Free PMC article.
References
-
- Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2018. CA Cancer J. Clin. 68, 7–30 (2018). - PubMed
-
- Siegel, R. L., Miller, K. D. & Jemal, A. Cancer Statistics, 2017. CA Cancer J. Clin. 67, 7–30 (2017). - PubMed
-
- Ferlay, J. et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int. J. Cancer 144, 1941–1953 (2019). - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous